BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 29129747)

  • 1. Mitochondrial SIRT3 and neurodegenerative brain disorders.
    Anamika ; Khanna A; Acharjee P; Acharjee A; Trigun SK
    J Chem Neuroanat; 2019 Jan; 95():43-53. PubMed ID: 29129747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease.
    Ansari A; Rahman MS; Saha SK; Saikot FK; Deep A; Kim KH
    Aging Cell; 2017 Feb; 16(1):4-16. PubMed ID: 27686535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of SIRT3 in mitochondrial biology and its therapeutic implications in neurodegenerative disorders.
    Mishra Y; Kaundal RK
    Drug Discov Today; 2023 Jun; 28(6):103583. PubMed ID: 37028501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial sirtuins.
    Huang JY; Hirschey MD; Shimazu T; Ho L; Verdin E
    Biochim Biophys Acta; 2010 Aug; 1804(8):1645-51. PubMed ID: 20060508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease.
    Lee J; Kim Y; Liu T; Hwang YJ; Hyeon SJ; Im H; Lee K; Alvarez VE; McKee AC; Um SJ; Hur M; Mook-Jung I; Kowall NW; Ryu H
    Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29130578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization.
    Yang W; Nagasawa K; Münch C; Xu Y; Satterstrom K; Jeong S; Hayes SD; Jedrychowski MP; Vyas FS; Zaganjor E; Guarani V; Ringel AE; Gygi SP; Harper JW; Haigis MC
    Cell; 2016 Nov; 167(4):985-1000.e21. PubMed ID: 27881304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Sirtuins and Molecular Mechanisms of Aging.
    van de Ven RAH; Santos D; Haigis MC
    Trends Mol Med; 2017 Apr; 23(4):320-331. PubMed ID: 28285806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System.
    Zhang H; Dai S; Yang Y; Wei J; Li X; Luo P; Jiang X
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT3 and mitochondrial metabolism in neurodegenerative diseases.
    Salvatori I; Valle C; Ferri A; Carrì MT
    Neurochem Int; 2017 Oct; 109():184-192. PubMed ID: 28449871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway.
    Park JH; Burgess JD; Faroqi AH; DeMeo NN; Fiesel FC; Springer W; Delenclos M; McLean PJ
    Mol Neurodegener; 2020 Jan; 15(1):5. PubMed ID: 31931835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.
    Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB
    Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3.
    Parodi-Rullán RM; Chapa-Dubocq XR; Javadov S
    Front Physiol; 2018; 9():1094. PubMed ID: 30131726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The yin and yang faces of the mitochondrial deacetylase sirtuin 3 in age-related disorders.
    Gomes P; Viana SD; Nunes S; Rolo AP; Palmeira CM; Reis F
    Ageing Res Rev; 2020 Jan; 57():100983. PubMed ID: 31740222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin3 in Neurological Disorders.
    Sherin F; Gomathy S; Antony S
    Curr Drug Res Rev; 2021; 13(2):140-147. PubMed ID: 33290206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Promising Strategy to Treat Neurodegenerative Diseases by SIRT3 Activation.
    Tyagi A; Pugazhenthi S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress.
    Scher MB; Vaquero A; Reinberg D
    Genes Dev; 2007 Apr; 21(8):920-8. PubMed ID: 17437997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SirT3 and p53 Deacetylation in Aging and Cancer.
    Chen J; Wang A; Chen Q
    J Cell Physiol; 2017 Sep; 232(9):2308-2311. PubMed ID: 27791271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Sirtuin 3 and Renal Diseases.
    Perico L; Morigi M; Benigni A
    Nephron; 2016; 134(1):14-9. PubMed ID: 27362524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of SIRT3 in mitochondrial dysfunction and cardiovascular diseases.
    Wu J; Zeng Z; Zhang W; Deng Z; Wan Y; Zhang Y; An S; Huang Q; Chen Z
    Free Radic Res; 2019 Feb; 53(2):139-149. PubMed ID: 30458637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated cellular redox status during hyperammonemia causes mitochondrial dysfunction and senescence by inhibiting sirtuin-mediated deacetylation.
    Mishra S; Welch N; Karthikeyan M; Bellar A; Musich R; Singh SS; Zhang D; Sekar J; Attaway AH; Chelluboyina AK; Lorkowski SW; Roychowdhury S; Li L; Willard B; Smith JD; Hoppel CL; Vachharajani V; Kumar A; Dasarathy S
    Aging Cell; 2023 Jul; 22(7):e13852. PubMed ID: 37101412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.